Basic Information
| LncRNA/CircRNA Name | EGOT |
| Synonyms | EGOT, EGO, NCRNA00190 |
| Region | GRCh38_3:4749192-4751590 |
| Ensemble | ENSG00000235947 |
| Refseq | NR_004428 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR, Western blot |
| Sample | gastric cancer tissues, cell lines (MGC80-3,AGS, NCI-N87, MKN-45 and SGC-7901, GES-1) |
| Expression Pattern | up-regulated |
| Function Description | The expression of EGOT was observably elevated in GC. Upregulation of EGOT was related with lymphatic metastasis and TNM stage. knockdown of EGOT by siRNA could significantly inhibit GC cell proliferation and arrest cycle progression in G1 phase. Moreover, EGOT mediated cyclin D1 expression in GC cells which was regulated by Hedgehog pathway. loss of EGOT downregulated Hedgehog signaling pathway in GC cells. EGOT functions as an oncogene in GC, and may be useful as a conceivable diagnostic and prognostic biomarker for GC tumorigenesis.low levels of EGOT expression had signally longer overall survival (OS) time than that in high-EGOT group. |
| Pubmed ID | 29209988 |
| Year | 2017 |
| Title | LncRNA EGOT Promotes Tumorigenesis Via Hedgehog Pathway in Gastric Cancer. |
External Links
| Links for EGOT | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |